Podcasts about jcvi

Respiratory syncytial virus (RSV) is very common and can cause disease ranging from mild upper respiratory tract infections to bronchiolitis, pneumonia or even death. In the UK, intensive care wards in the winter are extremely busy and 20,000 to 30,000 children are hospitalised with RSV each year. This is a disease that causes a huge burden in infants both in the UK and globally. Dr Simon Drysdale, a consultant in paediatric infectious disease, joins our hosts Dr Emma Lim and Dr Chisto Tsilifis to discuss the maternal RSV vaccine, which has been rolled out across the UK, plus advances in research and other recently licensed vaccines. RCPCH had a significant role in ensuring the RSV immunisation programme was introduced in the UK following publication of the JCVI's recommendation to develop one. In March 2024, we published an open letter signed by over 2,000 members urging the UK Government to implement a full RSV immunisation programme for both infants and adults across the UK. Our letter generated media coverage and UK parliamentary attention with MPs and Peers supporting our calls. As a result of our campaign, we welcomed announcements from all four UK governments confirming the rollout of new RSV programmes for infant protection from August 2024 in Scotland, and September for Northern Ireland, Wales and England. Dr Simon Drysdale is Consultant Paediatric Infectious Diseases Specialist at Oxford Children's Hospital and a Senior Lecturer in Vaccinology at the University of Oxford.  This podcast is a collaboration between the Royal College of Paediatrics and Child Health and Medisense. The views, thoughts and opinions expressed in this podcast relates only to the speaker and not necessarily to their employer, organisation, RCPCH or any other group or individual. Subscribe to The Paeds Round for more educational episodes! And, you can find more RCPCH educational resources on RCPCH Learning.  Want to hear more from RCPCH? Search for and subscribe to RCPCH Podcasts, our main channel.

FREEDOM - LIBERTY - HAPPINESS SUPPORT DOC MALIK To make sure you don't miss any episodes, please subscribe to either: The paid Spotify subscription here: ⁠https://podcasters.spotify.com/pod/show/docmalik/subscribe The paid Substack subscription here: ⁠https://docmalik.substack.com/subscribe Thank you to all the new subscribers for your lovely messages and reviews! And a big thanks to my existing subscribers for sticking with me and supporting the show! ABOUT THIS CONVERSATION: In this chat, I sit down with Dr Liz Evans to discuss why we need a medical freedom movement here in the UK, especially after everything we've seen during the COVID-19 pandemic. We talk about the ethical concerns around vaccine safety and informed consent. Liz opens up about her background as a former NHS doctor, her shift into complementary medicine, and how her Christian faith plays a huge role in her commitment to medical ethics. We also discuss how the UK Medical Freedom Alliance came to be and the worrying changes in public health legislation (Scotland, Canada, and now Northern Ireland) that could lead to government overreach. The conversation highlights why public resistance is so important and why we all need to take a stand. Ultimately, it's about fighting for a society that respects individual freedoms and upholds medical ethics. Ahmad x Links Website UK Medical Freedom Alliance X UKMFA X Proposed Public Health Bill Consultation Link UKMFA Open letter to JCVI, MHRA and Matt Hancock, in Nov 2020, urging them not to authorise or roll out the Covid vaccines due to serious safety & ethical concerns IMPORTANT INFORMATION AFFILIATE CODES Hunter & Gather Foods ⁠Hunter & Gather Foods Use DOCHG to get 10% OFF your purchase with Hunter & Gather Foods. IMPORTANT NOTICE Following my cancellation for standing up for medical ethics and freedom, my surgical career has been ruined. I am now totally dependent on the support of my listeners, YOU. If you value my podcasts, please support the show so that I can continue to speak up by choosing one or both of the following options - ⁠Buy me a coffee⁠ If you want to make a one-off donation. Join my Substack To access additional content, you can upgrade to paid from just £5.50 a month Doc Malik Merch Store⁠ Check out my amazing freedom merch To sponsor the Doc Malik Podcast contact us at ⁠hello@docmalik.com⁠ Check out my website, visit ⁠www.docmalik.com

Curious about how the new RSV vaccine could protect your baby? Join me, Florence, as we uncover the latest addition to the UK's maternal vaccination program. In this episode of the OBSpod, I break down everything you need to know about the respiratory syncytial virus (RSV) vaccine. Learn how this innovative recombinant vaccine works & why it's crucial for infants under a year old.Expectant mothers, healthcare professionals, and anyone interested in maternal and infant health will find this episode particularly enlightening. I'll guide you through the rationale behind the vaccine's introduction and its expected impact on both families and the NHS. We'll also revisit some key points from our previous discussions on pregnancy vaccinations, offering a well-rounded perspective on this significant healthcare advancement. Tune in to arm yourself with the knowledge needed to make informed decisions about the RSV vaccine or to confidently advise others about it.Want to know more?https://www.gov.uk/government/publications/respiratory-syncytial-virus-rsv-maternal-vaccination/a-guide-to-rsv-vaccination-for-pregnant-womenhttps://www.gov.uk/government/collections/respiratory-syncytial-virus-rsv-vaccination-programmehttps://www.gov.uk/government/publications/rsv-immunisation-programme-jcvi-advice-7-june-2023/respiratory-syncytial-virus-rsv-immunisation-programme-for-infants-and-older-adults-jcvi-full-statement-11-september-2023#:~:text=JCVI%20advised%20that%20a%20RSV,and%20conclusions%20of%20the%20committee.Thank you all for listening, My name is Florence Wilcock I am an NHS doctor working as an obstetrician, specialising in the care of both mother and baby during pregnancy and birth. If you have enjoyed my podcast please do continue to subscribe, rate, review and recommend my podcast on your podcast provider.If you have found my ideas helpful whilst expecting your baby or working in maternity care please spread the word & help theobspod reach other parents or staff who may be interested in exploring all things pregnancy and birth. Keeping my podcast running without ads or sponsorship is important to me. I want to keep it free and accessible to all but it costs me a small amount each month to maintain and keep the episodes live, if you wish to contribute anything to support theobspod please head over to my buy me a coffee page https://bmc.link/theobspodV any donation very gratefully received however small. Its easy to explore my back catalogue of episodes here https://padlet.com/WhoseShoes/TheObsPod I have a wide range of topics that may help you make decisions for yourself and your baby during pregnancy as well as some more reflective episodes on life as a doctor. If you want to get in touch to suggest topics, I love to hear your thoughts and ideas. You can find out more about me on Twitter @FWmaternity & @TheObsPod as well as Instagram @TheObsPod and e...

You will recall a previous podcast about preventing Neisseria gonorrhoea through an effective vaccine. Neisseria gonorrhoeae is a ubiquitous sexually transmitted bacteria that can cause both localised and systemic disease if left untreated. It may be transmitted to neonates. We also reported on a rise of the gonorrhoea incidence, as well as increasing rates of antibiotic resistance. Today we will revisit the implementation of vaccinations against gonorrhoea in the UK. Here is an exciting up-date on the advice provided by UK's Joint Committee on Vaccination and Immunisation, JCVI, on using the vaccine 4CMebB OMV against Meningococcus used off-label for the prevention of gonorrhoea infection • in patients at significant risk of infection with bacterial STIs who • attend specialist sexual health services. Host: Dr. Fabiola Martin, Sexual Health HIV, HTLV Specialist, Canberra Sexual Health Services & University of Queensland, Australia Participants: Dr. Suneeta Soni, Consultant in Sexual Health and HIV, University Hospitals Sussex and Chair of the Bacterial special interest group for BASHH *British Association for Sexual health and HIV) Dr. Yen Bui, Consultant in Vaccination and Travel Health, Institut national de santé publique du Québec, Canada A/P. Dr. Kate Seib, NHMRC Leadership Fellow and Associate Director for Research, Institute for Glycomics, Griffith University, Australia

J. Craig Venter, PhD, ( https://www.jcvi.org/about/j-craig-venter ) is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. Dr. Venter is founder, chairman, and CEO of the J. Craig Venter Institute (JCVI), a not-for-profit, research organization with approximately 120 scientists and staff dedicated to human, microbial, synthetic, and environmental genomic research, and the exploration of social and ethical issues in genomics. Dr. Venter began his formal education after a tour of duty as a Navy Corpsman in Vietnam from 1967 to 1968. After earning both a Bachelor of Science in biochemistry and a PhD in physiology and pharmacology from the University of California at San Diego, he was appointed professor at the State University of New York at Buffalo and the Roswell Park Cancer Institute. In 1984, he moved to the National Institutes of Health campus where he developed expressed sequence tags or ESTs, a revolutionary new strategy for rapid gene discovery. In 1992, Dr. Venter founded The Institute for Genomic Research (TIGR, now part of JCVI), a not-for-profit research institute, where in 1995 he and his team decoded the genome of the first free-living organism, the bacterium Haemophilus influenzae, using the new whole genome shotgun technique. In 1998, Dr. Venter founded Celera Genomics to sequence the human genome using new tools and techniques he and his team developed. This research culminated with the February 2001 publication of the human genome in the journal, Science. He and his team at Celera also sequenced the fruit fly, mouse, and rat genomes. Dr. Venter and his team at JCVI continue to blaze new trails in genomics. They have sequenced and analyzed hundreds of genomes, and have published numerous important papers covering such areas as environmental genomics, the first complete diploid human genome, and the groundbreaking advance in constructing the first self-replicating bacterial cell using synthetic DNA. Dr. Venter is one of the most frequently cited scientists, and the author of more than 280 research articles. He is also the recipient of numerous honorary degrees, public honors, and scientific awards, including the 2008 United States National Medal of Science, the 2002 Gairdner Foundation International Award, the 2001 Paul Ehrlich and Ludwig Darmstaedter Prize, and the King Faisal International Award for Science. Dr. Venter is a member of numerous prestigious scientific organizations including the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Society for Microbiology. Dr. Venter is also a serial entrepreneur who has co-founded several companies including Synthetic Genomics, Inc., now Viridos and Human Longevity, Inc. (HLI). Dr. Venter's newest book "The Voyage of Sorcerer II: The Expedition That Unlocked the Secrets of the Ocean's Microbiome" was recently released on September 12, 2023 - https://www.amazon.com/Voyage-Sorcerer-II-Expedition-Microbiome/dp/0674246470 Support the show

On today's show, Robin discusses the latest flare-up of violence in the Middle East and emphasizes the need for a permanent ceasefire and peace talks. Later, Clare discusses the recent JCVI recommendation that the chickenpox vaccine should be added to the childhood immunization schedule for all children in the UK. GUEST 1 OVERVIEW: Robin Monotti is an Italian architect, film producer, freedom warrior, and man-made climate-change critic based in London. GUEST 2 OVERVIEW: Dr. Clare Craig is a Co-Chair of the HART group and a Diagnostic pathologist. She has been a pathologist since 2001, working in the NHS. She specialized in cancer diagnostics and was the clinical lead for the data team, and led research and development projects at Genomics England.  

What's the smallest number of genes that cells need to grow and reproduce? Is it possible to synthesize minimal genomes and insert them into cells? What do minimal genomes teach us about life? In this episode, we talk to John Glass, leader of the Synthetic Biology Group at the J. Craig Venter Institute. Over the past decade, Glass and colleagues developed techniques for manipulating and synthesizing entire bacterial genomes. Starting with Mycoplasma bacteria, which have very small genomes, they determined the minimal number of genes (473!) required to support life. They experimentally confirmed this number by synthesizing genomes from scratch, containing just the essential genes, and putting them into other bacteria whose genomes were removed. Cells in this lineage, called JCVI-syn3.0, grow and divide approximately like wildtype cells do. We talk with John about how they pulled it off and what this minimal genome tells us about life more generally. We also chat about the functions of essential genes and what so-called non-essential genes may do in the wild. Finally, we touch on what if anything minimal genomes say about the origin of life and on the group's ongoing efforts to synthesize entire cells – not just genomes! – from scratch. Cover art by Keating Shahmehri

Join Andy and Gandhi for the latest news in technology-enhanced primary care and learning.Live Episode- GP News Catch UpWelcome… So much been going on in the worldGP stories that caught our eye…Living with COVIDGP FinancesHow are you?COVID-19 RESPONSE: LIVING WITH COVID-19 Changes at a glance P22https://www.gov.uk/government/publications/covid-19-response-living-with-covid-19 GPs express concern about practice infection control under ‘Living with Covid' planhttps://www.pulsetoday.co.uk/news/coronavirus/gps-express-concern-about-practice-infection-control-under-living-with-covid-plan NHS England told Pulse that continued Covid testing for GPs and practice staff is being reviewed, and will be updated before 1 April.IPC guidance no changesNHS staff ‘excluded' from free COVID-19 testing from AprilPrimary care leaders have demanded ‘urgent clarity' around free COVID-19 testing for NHS staff after the government suggested it would end from April.https://www.gponline.com/nhs-staff-excluded-free-covid-19-testing-april/article/1747656Vulnerable patients to receive additional Covid boosters in spring and autumnhttps://www.pulsetoday.co.uk/news/coronavirus/vulnerable-patients-to-receive-additional-covid-boosters-in-spring-and-autumn The JCVI has also advised UK governments that a further booster is likely to be advised ‘for people who are at higher risk of severe' Covid this autumn, with more definitive advice to come ‘in due course'.adults aged 75 years and over, residents in a care home for older adults; andindividuals aged 12 years and over who are immunosuppressed, as defined in in the Covid-19 healthcare guidance Green Book.Government suggests 2% pay uplift for salaried GPshttps://www.pulsetoday.co.uk/news/practice-personal-finance/government-suggests-2-pay-uplift-for-salaried-gps/Gov. talking of post COVID financial restraintGeneral NHS pay increase of 2%Inflation 5.5%???Real-terms GP income far below level a decade ago and set for further dropEvidence from the DHSC to the Doctors and Dentists Review Body (DDRB), which advises the government on pay, shows that average GP partner income in 2019/20 was £121,800 - down 15% in real terms compared with 2006/7.Salaried GP pay at £63,600 in 2019/20 is down 8.5% in real terms over the same period, figures quoted in the DHSC evidence showThe call for pay rises for salaried GPs and other practice staff to be limited to 2% comes despite the government backing a 3% rise last year that exceeded the level awarded through the five-year deal, leaving practices with huge unfunded rises in staff costs.https://www.gponline.com/real-terms-gp-income-far-below-level-decade-ago-set-further-drop/article/1747964£250m-a-year GP extended access scheme had ‘no measurable impact', finds studyhttps://www.pulsetoday.co.uk/news/contract/250m-a-year-gp-extended-access-scheme-had-no-measurable-impact-finds-study/ 2016 schemeLed by the University of Manchester, the study also reported no notable impact on continuity of care or overall patient satisfaction with general practice.Has been evidence to suggest reduced ED admissionsHelps some demographics more than othersJavid says GP access getting ‘back to normal' on England tourhttps://www.pulsetoday.co.uk/news/politics/javid-says-gp-access-getting-back-to-normal-on-england-tour ‘But now, since we're past the worst of that, services are getting backJoin the Medics Money New To GP partnership course for the leaders in finance, wellbeing, workload management, and your peers on the same journey to become a safe, effective, healthy GP partner. Join at medicsmoney.co.uk/gpcourse and reference eGPlearning

There have been big changes in flu vaccination in the last few years, with the offer of universal vaccination to those aged 50 or over, as well as to more children in secondary school. In this podcast, Dr Toni Hazell and Dr Uy Hoang discuss the future of flu vaccination. What factors will the JCVI have to consider when deciding who to vaccinate next year, and how much vaccine efficacy and uptake affect the decision making process? Funding was received via sponsorship from Seqirus to cover education on influenza. Seqirus has had no input in the content or been part of any reviews thereof. Editorial and content decisions were made solely by the RCGP.

In this podcast with Dave we talk about the recent U-turn of the vaccine mandate on NHS staff in England. We dive into talking about why NHS staff don't want to get vaccinated, should they get vaccinated and also how many of them would of lost there jobs if the vaccine mandates in the NHS went through. We also talk about the health in England addressing certain big issues like obesity as well as the mental health aspect of people living here. With me talking about it from a libertarian standpoint. We also talk about immigration in the UK specifically about nationalism, Nigel Farage and more. We also have a quite heated debate about gender pronouns and a lot of things to do with it diving into the multiple genders and language being mandated around it. While it did get heated at many points of the podcast we both learnt from each over and kept the conversation civil. I enjoyed and learnt a lot from this so I hope you did as well! Follow the Podcast - https://www.instagram.com/regpodcast/?hl=en Follow me - https://www.instagram.com/rory_jacobs_/?hl=en Follow Dave - instagram.com/dwrevans/?hl=en (00:00) - Introduction (03:00) - Who is our guest Dave? (08:10) - NHS 100K beating the Vaccine Mandates (10:22) - How many NHS staff do not want to take the Covid vaccine? (10:38) - Why tens of thousands of NHS staff do not want to take the Covid vaccine (19:59) - Why I am personally not taking the Covid vaccine (21:47) - The effect obesity has on how bad you get Covid (23:33) - The JCVI u turn on vaccinating young people (24:20) - The science on vaccinating children (32:14) - The politization of the Covid vaccine (33:15) - The Conservatives party's view on Covid measures (35:10) - NHS 100K (36:03) - Health v Covid (41:20) - Obesity in the UK (45:45) - The withdrawal of the vaccine mandate on NHS workers (01:11:57) - Channel 4 is it worth having in the UK? (01:14:40_ - Immigration and and open boarders in the UK (01:17:17) - The immigrant work ethic in the UK (01:17:30) - The problem with Nigel Farage (01:20:01) - Why immigration is core to the UK (01:21:34) - People in the UK are entitled? (01:22:21) - Why the podcast has made me so happy (01:23:45) - Gender debate (01:56:57) - Dave's view on my recent guest Heshy Tischler

In this podcast we are joined by a specialist paramedic who works for the NHS, and has worked frontline with numerous people with COVID for the past 2 years. He is also part of the NHS 100K movement in the UK and the together declaration. In this episode we discuss the vaccine, how it works, yellow card reporting system, NHS vaccine mandate and much more. The paramedic I interview has some real concerns about the efficacy of the COVID-19 Vaccine due to the amount of reports of adverse reactions and also deaths because of it in the UK. We specifically dive into talking about vaccinating young children for COVID-19 and the effect that it has been doing to particularly young boys. For example the drastic rise in myocarditis in young people which is more commonly seen in young boys which has made many major health professionals concerned about vaccinating children or just young people in general as there risk of getting COVID-19 bad as so tiny. It was such a pleasure to have this conversation with a frontline specialist paramedic at the NHS, as I learnt a lot and got a different perspective then what I am used to hearing on the vaccine and COVID in general in the UK. I want to add do not base your own personal health decisions off this video but instead speak to your own personal Doctor, do your own research and get multiple opinions from health professionals as well. As this is a UK libertarian podcast I really want to get all different opinions on and this podcast for sure shows that. So I hope you enjoy listening to it as much as I did making it. Follow the Podcast -(https://www.instagram.com/regpodcast/?hl=en) Follow the Medic - (https://www.instagram.com/medicmatt090/?hl=en) (02:20) - What it was like when COVID-19 first started in NHS (04:29) - The inflation of COVID-19 deaths in the UK (14:57) - Why did COVID-19 restrictions really happen? (31:05) - What it was like dealing with COVID-19 patients from the beginning (39:31) - What the UK government should of done to battle COVID-19 (40:49) - How diet and exercise effects how bad you get COVID-19 (41:15) - Boris Johnsons 2022 speech (47:40) - Mike Yeadon being silences across social media (52:10) - The spike protein in the vaccine and what it does (59:45) - Are ICU beds being taken up by the un vaccinated? (01:05:21) - The NHS staff that don't want to be vaccinated (01:10:19) - The Nursing home shortage of staff crisis in the UK (01:18:00) - How the UK government stopped people from getting vaccinated (01:19:14) concluding why the NHS specialist paramedic does not want to take the vaccine (01:19:59) - Is the vaccine causing Myocarditis in young people? (01:25:00) - Discussion about moderna vaccine being taking away across Europe due to the adverse reactions (01:29:50) - The JCVI u turn on vaccinating kids in the UK (01:31:39) - The yellow card reporting system in the UK for COVID side effects (01:34:54) - Deaths in England due to the vaccine (01:42:26) - Should the COVID vaccine be a choice? (01:44:40) - Vaccine adverse reactions on older people (01:48:46) - The difficulty knowing what to believe about the vaccine (01:56:04) - The issue with vaccine adverse reactions in the UK (01:58:29) - Doctors who are experiencing patients with adverse reactions like blood clots due COVID vaccine in the UK (02:05:05) - The together declaration

小額贊助支持本節目： https://pay.firstory.me/user/linshibi 今天記者會晚點整理。這篇我想談一下Omicron的疫調框列為何這麼困難。 Omicron最麻煩的是潛伏期可縮短到3天，還有發病前2~3天就可以傳染這兩個特性。 原本新冠病毒潛伏期平均落在4~5天，發病前2天開始可以傳染，所以一受到暴露後大概在第2~3天開始有傳染力，第4~5天發病。這中間比較有個時間差。疫調框列多半來得及。 Omicron潛伏期可縮到3天，加速了這個傳染鏈，一受到暴露後大概在1天內就可以有傳染力，第3天發病。看看這群銀行員，如果都是指標個案案17630在尾牙傳給大家的，7日辦尾牙，之後10日發病者有高達6人，9日發病3人，而案17630自己則是在10日才開始發燒。他自己的潛伏期6天，在無症狀時傳給大家，然後和他傳染的多人一起發病。這病毒一代傳一代的速度真是可以非常快，疫調辛苦的在後面追真的會比Delta更困難多多！ 10號銀行接獲通報自主健康管理，自主管理還是可以外出可以和家人接觸。這些集中在１月９～10日發病的銀行員，他們大概尾牙後１月８日開始就有傳染力了。 這仗真的不好打，有可能已經傳出去了。 前線辛苦的擋，是要爭取時間讓高風險族群打好打滿疫苗的。（我每天都要講一次）和各位說個好消息，英國疫情確診數和PCR陽性率已在下降，倫敦住院數重症插管已在下降，他們的老人家可是疫苗打好打滿，50歲以上91％都打完三劑呀！英國資料針對65歲以上看疫苗對Omicron的效力，兩劑疫苗防住院在三個月是70％，六個月會降到50％。打上第三劑後三個月則在90％左右。 因此，英國JCVI說目前無施打第二劑追加劑之必要（第四針）。 歡迎追蹤前台大感染科醫師。04b的發聲管道！ 我的電子名片 https://lit.link/linshibi 希望大家當我的種子教師，推廣正確的新冠衛教。科學防疫，不要只以恐懼防疫！ 歡迎贊助林氏璧孔醫師喝咖啡，讓我可以在這個紛亂的時代，繼續分享知識努力做正確新冠相關衛教。 https://pay.firstory.me/user/linshibi Powered by Firstory Hosting

台灣一開始衝第一劑覆蓋率為主，僅有第一到第三類先打第二劑。第二劑覆蓋率，從九月底開始這兩個月從4.5%衝到45%。因此算來，我們第一第三類的朋友，第二劑後六個月該考慮打加強針的時間，會落在明年1~3月之間。其他絕大多數的人，是從明年3月開始陸續滿6個月。 阿中部長上周在記者會上回答關於加強針的問題說，"會讓民眾以接種同廠牌的疫苗為主，但也不排除混打"，這回答不太精確。 世界各國加強針都是以mRNA疫苗為主。AZ兩劑後再以AZ作為加強針，幾乎沒資料。且連施打AZ最多的英國，都是這樣建議的： 1.不管前兩劑打什麼，首選都是一劑BNT（30微克），或是半劑量莫德納（50微克）。 2.若前兩劑AZ者，對於mRNA疫苗使用有禁忌症，則可以用AZ作為加強針。 英國是根據加強針混打研究 COV-BOOST trial做出以上決定。連英國自己都沒有用AZ主要用於加強針，部長的觀念該改改了。 很可惜的是，COV-BOOST到目前都沒有完整公布。這是在AZAZ還有BNTBNT之後，打七種疫苗做為加強針。全世界都在做加強針的決定，應該很需要這資料，英國不知道為何藏成這樣... 至於美國嬌生疫苗加強針打什麼呢？根據NIH進行的小規模混打研究，再打嬌生疫苗產生的抗體遠不及施打mRNA疫苗。因此美國是建議加強針選三種疫苗皆可。並沒有以同廠牌疫苗為主喔。 腺病毒載體疫苗適合先施打，然後以mRNA疫苗加強。這已經是趨勢了。因為身體會產生對於腺病毒外殼的抗體，第三次以上再打同樣疫苗，理論上效果有限了。 牛津大學有一篇去做了三針AZ的結果，收案90人，其IgG抗體和T細胞免疫大概可達第二劑後最高值的兩倍，針對變種病毒的中和抗體也有升高。這篇研究很有名，就是第二針還拖到44~c45週打的那篇。但英國還是建議打mRNA。我相信他們都考量過了這些資料。至於AZ的次世代疫苗，詢問過葉醫師，的確也有在規劃做研究，但估計應該是趕不上在多半台灣朋友需要施打的明年三月，如果你考慮臨床試驗，採購還有疫苗來到台灣的時間。 至於是否可以用次單位蛋白疫苗來做為加強針？不良反應較少的蛋白疫苗應該是很適合作為後續接種的加強針。高端自己已經有三劑高端的初步結果（還去ＷＨＯ報告過），我也很期待國內臨床試驗針對高端做為第三劑（長庚將進行兩劑AZ後以不同疫苗作為第三劑的研究，台大也在規劃中），還有COV-BOOST用Novavax做為兩劑AZ後加強針的結果。 美國CDC的建議 https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html 英國JCVI的建議 https://www.gov.uk/government/publications/jcvi-statement-september-2021-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-statement-regarding-a-covid-19-booster-vaccine-programme-for-winter-2021-to-2022 COV-BOOST trial 網頁 https://www.covboost.org.uk/about Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) https://www.thelancet.com/article/S0140-6736(21)01699-8/fulltext 追加第3劑疫苗有望 陳時中：最快明年1月底 https://health.ltn.com.tw/article/breakingnews/3742050 小額贊助支持本節目： https://pay.firstory.me/user/linshibi Powered by Firstory Hosting

今天這集錄音於星期五11月19日，當天美國正要開會決定加強針政策，因此這集主要還是先說英國和日本。美國會在下一集詳細說明。但我也先把資料附上。 1.美國政府曾在8月直接宣布9月20日那週，所有18歲以上成人皆可施打加強針。中間專家們有種種意見，認為不需要全部成人都打，做出種種設限。 2.但隨著美國疫情再次升溫，還有累積更多的資訊之後，FDA和CDC還是做出了和白宮當時一樣的決定。比白宮當時預訂執行日期晚了兩個月。 3.在11月19日，FDA早上火速通過了輝瑞和莫德納加強針在18歲以上使用的授權，下午CDC ACIP專家會議全票通過加強針18歲以上皆可施打。 4.強烈建議施打者，則從原本的65歲以上，下修到50歲以上。 美國預計9月下旬成人追打第3劑新冠疫苗加強針 與第2劑須隔8個月 https://linshibi.com/?p=39667 英國11月15日JCVI宣布加強針往下到40-49歲 https://www.gov.uk/government/publications/covid-19-booster-vaccine-programme-for-winter-2021-to-2022-jcvi-statement-november-2021 11月15日日本厚勞省開會資料 https://www.mhlw.go.jp/stf/shingi2/0000192554_00014.html 美國加強針，18歲以上皆可施打。強烈建議施打者，從65歲以上下修到50歲以上。 FDA新聞稿 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-covid-19-vaccine-boosters CDC新聞稿 https://www.cdc.gov/media/releases/2021/s1119-booster-shots.html CDC ACIP開會資料 11票全票通過 https://youtu.be/_2y6jKyHu9A https://www.cdc.gov/vaccines/acip/meetings/slides-2021-11-19.html 新聞 U.S. expands COVID-19 booster eligibility to all adults https://www.reuters.com/world/us/covid-19-boosters-for-all-discussion-moves-cdc-2021-11-19/ CDC expands eligibility for Covid-19 booster shots to all adults https://www.statnews.com/2021/11/19/covid19-vaccine-boosters-cdc-vote-pfizer/ 小額贊助支持本節目： https://pay.firstory.me/user/linshibi Powered by Firstory Hosting

Britain's booster programme for COVID-19 vaccinations is to be expanded to younger people after scientists gave the green light. The UK government's Joint Committee on Vaccination and Immunisation says all healthy adults aged 40-49 should be offered a booster, six months after their second dose. The booster programme was limited to those aged 50 and over, and the clinically vulnerable. Some 12.6 million Britons have received the third jab. The JCVI says that 16 and 17-year-olds should now be offered a second dose of the Pfizer/BioNTech jab.

Britain's booster programme for COVID-19 vaccinations is to be expanded to younger people after scientists gave the green light. The UK government's Joint Committee on Vaccination and Immunisation says all healthy adults aged 40-49 should be offered a booster, six months after their second dose. The booster programme was limited to those aged 50 and over, and the clinically vulnerable. Some 12.6 million Britons have received the third jab. The JCVI says that 16 and 17-year-olds should now be offered a second dose of the Pfizer/BioNTech jab.

Britain's booster programme for COVID-19 vaccinations is to be expanded to younger people after scientists gave the green light. The UK government's Joint Committee on Vaccination and Immunisation says all healthy adults aged 40-49 should be offered a booster, six months after their second dose. The booster programme was limited to those aged 50 and over, and the clinically vulnerable. Some 12.6 million Britons have received the third jab. The JCVI says that 16 and 17-year-olds should now be offered a second dose of the Pfizer/BioNTech jab.

Winter is coming...and as the nights draw in there's a warning from our recent past - could we see Covid cases overwhelm hospital beds, and should we ride it out or batten down the hatches once more? As Business Secretary Kwasi Kwarteng rules out another lockdown, we talk data and risk for the months ahead with Professor Adam Finn, a member of the Government's vaccination advisory body the JCVI. His warnings come as the UK registered 43,738 confirmed Covid cases, with the Government still hoping to avoid implementing its Plan B, which includes Covid-status certification in certain settings, legally mandating face coverings and asking more people to work from home if they can.The Government has so far dismissed appeals to introduce its Plan B Covid restrictions with ministers saying the vaccine booster programme and plan to immunise children aged between 12 and 15 will avoid the need for tighter restrictions even as the NHS battles winter flu and a backlog of non-Covid treatment. See acast.com/privacy for privacy and opt-out information.

1.經過八小時的討論，美國FDA的專家諮詢委員會以16比2的投票結果，反對在施打六個月後為16歲及以上人群接種BNT新冠疫苗加強針。至於65歲以上的年長者人和重症高風險人群的加強針，則是以18票全票通過。 全場會議影片 https://youtu.be/WFph7-6t34M FDA advisory panel recommends booster doses of Covid-19 vaccine only for older and high-risk Americans ⁠https://www.statnews.com/2021/09/17/fda-advisory-panel-recommends-against-booster-doses-of-covid-19-vaccine-for-most-americans/ Tracking the FDA advisory panel meeting on Covid-19 booster shots （live報導） https://www.statnews.com/2021/09/17/tracking-the-fda-advisory-panel-meeting-on-covid-19-booster-shots/ 2.這項決定等於打臉白宮日前繞過FDA和CDC，逕自宣布讓所有成人都打加強針的政策。FDA不一定需要完全採納專家委員會的建議，但FDA通常都會照專家委員會建議來做。 3.CDC的疫苗諮詢委員會下周會開會，對何謂重症高風險人群做出定義。此外，許多委員也表示醫護人員或其他職業上高風險人員本身染疫雖然可能不是重症高風險，但也應該加入考慮中。 04b解讀： 1.這個決定會讓美國對加強針的建議比英國還保守。複習一下： 英國疫苗接種和免疫聯合委員會（JCVI）建議在接種第2劑疫苗6個月後，追加第3劑。包括以下六類人群： 長照機構住民 50歲以上成人 前線醫護人員和社工人員 16~49歲但有新冠重症因子的慢性病 免疫缺乏患者的同住者 2.多數專家們同意資料顯示疫苗的保護力在下降，但此刻對於重症還有死亡的保護力還是足夠的。且目前資料無法確認到底是因為時間因素，還是是因為Delta病毒本身造成所見的抗體和保護力下降。 3.而且打加強針可能帶來其他風險，目前第三劑的資料尚少，衝上來的中和抗體和保護力到底可維持多久？長期的安全性也還有待評估。（輝瑞加強針此次送審僅包括了12位 65~85歲，還有289位18~55歲的臨床試驗資料） 4.專家們同意對一般健康人的加強針最終可能還是需要的，但問題是，何時是最佳的時機。 5.白宮自己率先宣布了要給所有成人打加強劑，但現在不受到FDA多數專家委員會成員的支持。用科學證據說話，全部記名投票，線上直播，每個專家都侃侃而談自己反對或贊成的理由。這是我樂於看到的科學透明度和正向的討論。我期待台灣對於科學相關議題，也能進行這樣的專家理性論辯，公開透明。 Delta變種病毒懶人包！ Podcast版 https://linshibi.pros.is/3pankg 部落格版 https://linshibi.com/?p=39717 各國分年齡的新冠致死率 https://linshibi.com/?p=35732 混打疫苗可行嗎？AZ混打輝瑞/BNT AZ混打莫德納等等 https://linshibi.com/?p=39613 給長輩的AZ疫苗懶人包 https://linshibi.com/?p=39590 高端 聯亞 國產疫苗懶人包 第二期結束就緊急授權可行嗎？ https://linshibi.com/?p=39547 新冠快篩懶人包 普篩 抗體快篩 抗原快篩 https://linshibi.com/?p=36564 新冠肺炎疫情下的防疫須知 常見問題解答FAQ https://linshibi.com/?p=35408 新冠疫苗常見問題懶人包 https://linshibi.com/?p=38945 林氏璧醫師的電子名片 https://lit.link/linshibi Powered by Firstory Hosting

#英國建議50歲以上施打加強針 #接下來是美國要做決定了 1.英國疫苗接種和免疫聯合委員會（JCVI）建議在接種第2劑疫苗6個月後，追加第3劑。包括以下六類人群： 長照機構住民 50歲以上成人 前線醫護人員和社工人員 16~49歲但有新冠重症因子的慢性病 免疫缺乏患者的同住者 2.建議要施打加強針的理由，是基於英國公衛部PHE的初步資料顯示，對於年長者防重症的效力會逐漸下降。目前大概是追蹤到第二劑後六個月，雖然還不確定若觀察6~12個月會如何，但因為面臨冬天的到來，英國決定採取比較預防性的作法，以加強針來維持易重症族群對重症的保護力。 3.建議不論前面施打什麼疫苗，都以一劑BNT疫苗作為第3劑。因為根據COV-BOOST trial研究結果，BNT一劑不良反應可耐受，且有很強的加強效果。 另一個替代選擇，可以使用半劑莫德納疫苗。若無法使用mRNA疫苗的情形，比方說過敏，則可使用AZ作為第三劑。 4.這群會優先開打加強針的人也是流感疫苗的施打族群。根據 ComFluCOV trial的研究結果，新冠和流感疫苗一起施打的耐受性佳，且不會影響抗體生成。因此英國建議可以同時施打新冠和流感疫苗。 5.至於50歲以下較年輕族群，距離打完第二劑時間可能還不久，英國會稍晚再評估這些人是否需要加強針。JCVI會持續檢視這些人兩劑免疫力的持續狀況。 6.符合這些條件的英國人大約是3000萬人，大概是英國人口的近一半。 04b解讀： 1.Lancet前幾天出了一篇科學家們憂心忡忡覺得目前廣泛施打加強針的證據是不足的，因為各疫苗對於重症的保護力幾乎都還維持的不錯。其實如同白宮對加強針的想法，也是預防性的打，研究上並沒有看到防重症的效果下降太多。 2.在Delta的時代，疫苗防重症的意義可能已經遠大於防感染的意義了。追求防感染的保護力，把抗體短暫的衝到高點，真的是最好的作法嗎？應該用什麼劑量最好？長期的安全性，有效性如何？其實很多事情我們都還沒有答案。 3.有錢國家競相施打加強針，但加強劑多給的保護，對整個疫情控制的效果肯定是沒有打在一個完全還沒打過疫苗的人好。WHO因此多次呼籲有錢國家可否延遲加強針計畫，至少讓更多人都打到第一劑後再開始。 4.但看來各有錢國家的加強針是箭在弦上了。至少英國還是選擇了一部分比較容易重症的族群來施打，不像以色列已經宣布12歲以上都可打加強針，也不像美國預計18歲以上都可打加強針。 5.對台灣來說，請大家稍安勿躁。第三針前你要先有第一和第二針呀！這些免疫下降是打完第二劑後６～８個月之後的事，台灣面對這個問題應該是明年初的事情了。我們看看這些國家打第三劑的資料，再慢慢做決定即可。 下周，輪到美國傷腦筋了.... 英國建議50歲以上追加第3劑疫苗 https://www.cna.com.tw/news/aopl/202109140373.aspx JCVI issues updated advice on COVID-19 booster vaccination https://www.gov.uk/government/news/jcvi-issues-updated-advice-on-covid-19-booster-vaccination Lancet：Considerations in boosting COVID-19 vaccine immune responses https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02046-8/fulltext 國際疫苗「貧富不均」 世衛籲富國：年底前別打補強針 https://udn.com/news/story/121707/5733200 Delta變種病毒懶人包！ Podcast版 https://linshibi.pros.is/3pankg 部落格版 https://linshibi.com/?p=39717 各國分年齡的新冠致死率 https://linshibi.com/?p=35732 混打疫苗可行嗎？AZ混打輝瑞/BNT AZ混打莫德納等等 https://linshibi.com/?p=39613 給長輩的AZ疫苗懶人包 https://linshibi.com/?p=39590 高端 聯亞 國產疫苗懶人包 第二期結束就緊急授權可行嗎？ https://linshibi.com/?p=39547 新冠快篩懶人包 普篩 抗體快篩 抗原快篩 https://linshibi.com/?p=36564 新冠肺炎疫情下的防疫須知 常見問題解答FAQ https://linshibi.com/?p=35408 新冠疫苗常見問題懶人包 https://linshibi.com/?p=38945 林氏璧醫師的電子名片 https://lit.link/linshibi Powered by Firstory Hosting

Steven醫師：美國的第三劑政策，德州已經出現Mu變種株，開學狀況，醫師不給伊維菌素（Ivermectin）被告。 Pauline：英國的公立學校不戴口罩，開學狀況，青少年疫苗政策。 葉庭瑜醫師：我因為疥瘡吃過伊維菌素！英國JCVI還是不建議給12~15歲健康青少年接種新冠疫苗，16~17歲只打一劑mRNA減低心肌炎的風險（避重救心），解讀英國突破性感染研究，第三劑有分兩種，以色列的第四劑。 Scientists not backing Covid jabs for 12 to 15-year-olds https://www.bbc.com/news/health-58438669 Chief medical officers to consider vaccinating people aged 12 to 15 following JCVI advice https://www.gov.uk/government/news/chief-medical-officers-to-consider-vaccinating-people-aged-12-to-15-following-jcvi-advice Delta變種病毒懶人包！ Podcast版 https://linshibi.pros.is/3pankg 部落格版 https://linshibi.com/?p=39717 各國分年齡的新冠致死率 https://linshibi.com/?p=35732 混打疫苗可行嗎？AZ混打輝瑞/BNT AZ混打莫德納等等 https://linshibi.com/?p=39613 給長輩的AZ疫苗懶人包 https://linshibi.com/?p=39590 高端 聯亞 國產疫苗懶人包 第二期結束就緊急授權可行嗎？ https://linshibi.com/?p=39547 新冠快篩懶人包 普篩 抗體快篩 抗原快篩 https://linshibi.com/?p=36564 新冠肺炎疫情下的防疫須知 常見問題解答FAQ https://linshibi.com/?p=35408 新冠疫苗常見問題懶人包 https://linshibi.com/?p=38945 林氏璧醫師的電子名片 https://lit.link/linshibi Powered by Firstory Hosting

Church of England vicars Tom and Jamie sit down to talk about the week's news, including: Sajid Javid says that parental consent will not be needed for the jab rollout for 12-15s after the decision on the jabs was re-delegated to the Chief Medical Officer because the JCVI did not recommend it; the government denies that there will be a lockdown this October, despite somebody leaking the possibility of one to the press; the Texas abortion "heartbeat" law that makes illegal any abortion that takes place in the state of Texas after six weeks; and the exciting news that Jeff Bezos is funding an anti-ageing startup in the hope of finding the key to eternal life.Our Scripture this week is taken from Luke 12:15-21, the Parable of the Rich Fool.Notices:Thanks to our Patreons! Support us from £1.50 plus VAT per month: https://patreon.com/irreverendIrreverend Weekly Sermon Audio: https://irreverendsermonaudio.buzzsprout.comTwitter: https://twitter.com/IrreverendPodTelegram: https://t.me/irreverendpodEmail: irreverendpod@gmail.comYouTube: https://www.youtube.com/channel/UCMAcRZPstCujEN4p8dF_ClQOdysee: https://odysee.com/@irreverend:5Audio Podcast: https://irreverend.buzzsprout.comLinks:12-15 year olds to get final say on the jabUK Medical Freedom Alliance open letter to headteachers on vaccinationOctober LockdownJeff Bezos funds anti-ageing startupIncrementalism and the Texas Abortion Law, Doug Wilson Support the show (https://www.patreon.com/irreverend)

The Joint Committee on Vaccines and Immunisation (JCVI) is recommending that a third jab be offered to people with weakened immune systems but the programme and rollout are different to the Covid vaccine boosters expected to be discussed by the JCVI later on Thursday. Shivani Dave speaks to professor of immunology and infectious disease at the University of Edinburgh, Eleanor Riley, and the Guardian science correspondent, Nicola Davis, about the distinctions between booster jabs and third jabs Coronavirus – latest updates. Help support our independent journalism at theguardian.com/sciencepod

On 3 September, the government advisory group - the JCVI - decided not to recommend the mass vaccination of healthy 12 to 15-year-olds and the final decision was left with the UK's four chief medical officers.On the Sky News Daily podcast with Sarah Hewson, we hear how parents feel about it as Dominic Wilkinson, a medical ethics professor at the University of Oxford, and chair of the Scientific Advisory Board Professor Jeffery Almond look at the arguments for and against. Plus, family law expert and barrister Gemma Lindfield explains the legalities around children and consent to treatment.Daily podcast team:Senior podcast producer - Annie JoycePodcast producer - Nicola EyersPodcast producer - Emma-Rae WoodhouseInterviews producer - Tatiana AldersonPodcast researcher - Rosetta FourlagawoArchive - Simon WindsorArchive - Rob FellowesArchive - Nelly StefanovaMusic - Steven Wheeler

We start the week in County Durham where James travels to see Kynren, the outdoor show that’s “a romp through 2,000 years of English history from the masks of the Roman invaders to the masks of Arthurian legend to the masks of Queen Victoria. Did we say that they were all wearing masks? Then it’s on to the more serious: the Government’s incomprehensible decision to press on with its vaccine passport plans and the horror of vaccinating healthy 12-15 year-olds in the teeth of their parents’ opposition. In Culture Corner we cover Shang-Chi and The Legend of the 10 Rings (Marvel/Disney),  the new submarine drama Vigil (BBC One),  and The Chair (Netflix). This week’s opening sound is of JCVI member Adam Finn on vaccinating children courtesy of The Guardian.

Joe Rogan catches the rona and destroys it with Ivermectin and the mainsteam hate it.The Taliban are now the good guys and are taking on the new ISIS KUK Government ignore the JCVI advice to not vaccinate 12-15 year oldssupport us here https://www.buymeacoffee.com/whatkastmerch store http://tee.pub/lic/l7YvevGN0SU

The JCVI has surprised parents and politicians by advising against Covid-19 vaccines for most 12 to 15 year olds. With Michael Walker, Anthony Costello and Aaron Bastani.

The JCVI has surprised parents and politicians by advising against Covid-19 vaccines for most 12 to 15 year olds. With Michael Walker, Anthony Costello and Aaron Bastani.

Paying for social care: National Insurance hike threatens jobs recovery, Johnson warnedLen Shackleton: The proposed social care plan is intergenerational robberyTaha Lokhandwala: The Tories' plan to fund care spells the end of the pensions triple lockNational Insurance: Three simple ways to reduce the amount you payCovid liveblog: JCVI rule out vaccines for healthy 12- to 15-year-oldsSpencer, review: Kristen Stewart is masterful as Diana in gutsy filmDrastic downsizing: 'Why we gave up our Georgian family home - for a tiny city flat'Swedish songsters return: The 10 best ABBA songs, rankedSummer sale: You can gain access to all these articles and more for three months for just £1. Here's how: https://bit.ly/3iAf6vFSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Allison's in the BMA's bad books. Hell hath no fury like a Pearson scorned as she shares her prescription with her podcast co-pilot, Liam Halligan for the next stage in her fight to bring back face-to-face GP appointments. Also on the show: it's the start of a new school year, but new books don't spell an end to the disruptions for our children. Liam has some disquieting words for the teaching unions ahead of the national return to the classroom.Also boarding the rocket of right-thinking, Professor Carl Heneghan, Director of Oxford University's Centre for Evidence-Based Medicine drops in to tell our co-pilots why he believes the JCVI should prioritise a vaccine booster programme for over 65s over the immunisation of under-18s - and leaves our co-pilots wishing he were their GP.Allison will be replying to comments beneath this article on Thursday 2nd September 11am-12pm: https://www.telegraph.co.uk/opinion/2021/09/02/children-not-showing-symptoms-covid-should-stay-school-says/ |Read more from Allison: https://www.telegraph.co.uk/authors/allison-pearson/ |Read more from Liam: https://www.telegraph.co.uk/authors/liam-halligan/ |Listen to Chopper's Politics: https://www.playpodca.st/chopper |Need help subscribing or reviewing? Read more about podcasts here: https://www.telegraph.co.uk/radio/podcasts/podcast-can-find-best-ones-listen/ |Email: planetnormal@telegraph.co.uk |For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/normal |See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dominic Raab was hauled before the Foreign Affairs Committee today to answer questions about how the government handled the withdrawal from Afghanistan. The Foreign Secretary faced tough questions about being on holiday during the crisis, risk reports produced from his own department, and whether a portrait of the Queen in Britain's Kabul embassy was taken by Taliban militants. How did he fare? Cindy Yu also speaks to James Forsyth and Katy Balls about whether China will fill the vacuum left by the West, and whether tension is emerging between the government and the JCVI. 

The U.K. plans to offer coronavirus vaccines to 16 and 17-year-olds in the next few weeks after the independent body of scientists that makes vaccine recommendations to the government changed its advice.The four nations of the U.K. all accepted the change from the Joint Committee on Vaccination and Immunization, which now says healthy 16 to 17-year-olds can be offered a first dose of the Pfizer vaccine. They will not need parental consent.The change, which means another 1.4 million people across the U.K. will be eligible for a first vaccine shot, comes just two weeks after the JCVI recommended against routine vaccinations for those under 18, although it did stress that it would continually assess the evidence.Currently, the only 16 and 17-year-olds being offered the Pfizer vaccine, which has been approved by Britain's medical regulator for anyone 12 and over, are those with underlying health conditions or those living with vulnerable people."While COVID-19 is typically mild or asymptomatic in most young people, it can be very unpleasant for some and for this particular age group, we expect one dose of the vaccine to provide good protection against severe illness and hospitalization," said Professor Wei Shen Lim, who chairs the JCVI's COVID-19 program.The timeline for when the 16 and 17-year-olds will get their second dose has yet to be determined but the scientists will make further recommendations later based on the response to the first dose.While the British vaccine rollout has been one of the world's fastest — with 89% of adults having had one dose and 73% of adults fully vaccinated — the country has been fairly slow in offering vaccine jabs to youths. There have been growing calls for the vaccination drive to be expanded to younger people following a spike in infections this summer as a result of the more transmissible delta variant and the lifting of lockdown restrictions.Despite Wednesday's change, the U.K. still lags many other European countries such as France and Germany, which are offering vaccines to children 12 and over. Britain's JCVI said it will constantly review the data on vaccinating under-16s and update its position accordingly.Professor Jonathan Van-Tam, England's deputy chief medical officer, said there was "no time to waste" and that he expects the rollout to start in "a very short number of weeks," which will coincide with the reopening of schools after the summer break.The expanded rollout comes amid evidence that the vaccination drive among younger adults in Britain has slowed down in recent weeks, a trend that's prompted the British government to offer incentives like discounts and free pizza to persuade young people to get the shot.Wei Shen Lim, the JCVI's chair, said there had been feedback from some young people who want to have a choice."So, they'd like to be offered the vaccine, understand the risks and potential benefits, and therefore make a choice for themselves whether they want to have it or not," he said.British Prime Minister Boris Johnson, on a visit Wednesday to Scotland, backed the scientists on their revised position."I would just urge all families thinking about this across the country to listen to the JCVI," he said.- by PAN PYLAS, Associated Press

The group that advises the government on vaccinations - the Joint Committee on Vaccination and Immunisation (JCVI) - has released interim guidance about Covid booster jabs in the coming winter. The JCVI says those who are clinically extremely vulnerable, NHS and social care staff and the over-70s should be prioritised but booster shots for the under-50s will also be considered. Today programme's Mishal Husain spoke to Prof Anthony Harnden, deputy chair of the JCVI, and put to him some questions which were emailed by our listeners. (Image: Oxford-AstraZeneca Covid vaccine vial and syringe; Credit: Reuters)

One week from today, Boris Johnson has a big decision to make. Is it time to declare 'freedom day' on the 21st of June? Or could the government be walking into another mistake?This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today and get one month free at: thetimes.co.uk/storiesofourtimes. Guests: - Henry Zeffman, chief political correspondent, The Times.- Ravi Gupta, professor of clinical microbiology at the University of Cambridge and member of NERVTAG.- Adam Finn, professor of paediatrics at Bristol Medical School, head of Bristol Children's Vaccine Centre and member of the JCVI.- Robert Read, professor of infectious diseases at the University of Southampton and member of the JCVI.- Christina Pagel, professor of operational research at University College London and member of Independent SAGE.- Tim Spector, professor of genetic epidemiology at King's College London and principal investigator of the ZOE Covid symptom study app.Host: Manveen Rana.Clips from: Times Radio, Channel 4 News, BBC, Sky News. See acast.com/privacy for privacy and opt-out information.

A closer look at the UK’s single-use plastic problem We dive into the UK’s use of single-use plastics. Where’s it coming from? Where’s it ending up? And what needs to change? We speak to our Science Editor, David Shukman and TV presenter Julia Bradbury, who wants us to dump the plastic… just not in Turkey. And Boris Johnson is continuing to urge caution when it comes to the Indian variant and says the government is keeping close tabs on cases in areas like Bolton and Bedford. We speak to Professor Anthony Harnden, Deputy Chair of the JCVI about vaccine hesitancy and if we’re still on track to for the next stage of lockdown easing. This episode of Newscast was made by Emma Close with Alix Pickles, Georgia Coan, Maz Ebtehaj, Emma Crowe and Rick Kelsey. The editor is Dino Sofos.

Health Secretary Matt Hancock says if the Indian variant is 50% more transmissible than the Kent variant, it will cause "problems" for the lockdown easing roadmap. He says local lockdowns could return, and defends the government against the charge that it was too slow to stop travel from India. Sir Mark Walport, former Chief Scientific Adviser, raises concerns about Monday's easing of restrictions. Adam Finn of the JCVI says the Astra-Zeneca vaccine could now be given to under-40s.

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Emma Scott, section editor, updates us on vaccination and the risk of blood clots. And Abigail Davis, GP and section editor, covers acute kidney injury, venous thromboembolism prevention, and secondary bacterial pneumonia. For more, see: BMJ Best Practice's topic on covid-19: bestpractice.bmj.com/topics/en-gb/3000168 BMJ Learning module on COVID-19 rapid guideline on critical care (NICE): new-learning.bmj.com/course/10065100 BMJ Learning covid-19 in primary care module: new-learning.bmj.com/course/10065230 EMA: ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood MHRA: gov.uk/government/news/mhra-issues-new-advice-concluding-a-possible-link-between-covid-19-vaccine-astrazeneca-and-extremely-rare-unlikely-to-occur-blood-clots JCVI: gov.uk/government/publications/use-of-the-astrazeneca-covid-19-vaccine-jcvi-statement/jcvi-statement-on-use-of-the-astrazeneca-covid-19-vaccine-7-april-2021 WHO: who.int/news/item/07-04-2021-interim-statement-of-the-covid-19-subcommittee-of-the-who-global-advisory-committee-on-vaccine-safety COVID-19 rapid guideline: managing COVID-19: nice.org.uk/guidance/NG191 - The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner's judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Emma Scott, section editor, updates us on vaccination and the risk of blood clots. And Abigail Davis, GP and section editor, covers acute kidney injury, venous thromboembolism prevention, and secondary bacterial pneumonia. For more, see: BMJ Best Practice's topic on covid-19: bestpractice.bmj.com/topics/en-gb/3000168 BMJ Learning module on COVID-19 rapid guideline on critical care (NICE): new-learning.bmj.com/course/10065100 BMJ Learning covid-19 in primary care module: new-learning.bmj.com/course/10065230 EMA: ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood MHRA: gov.uk/government/news/mhra-issues-new-advice-concluding-a-possible-link-between-covid-19-vaccine-astrazeneca-and-extremely-rare-unlikely-to-occur-blood-clots JCVI: gov.uk/government/publications/use-of-the-astrazeneca-covid-19-vaccine-jcvi-statement/jcvi-statement-on-use-of-the-astrazeneca-covid-19-vaccine-7-april-2021 WHO: who.int/news/item/07-04-2021-interim-statement-of-the-covid-19-subcommittee-of-the-who-global-advisory-committee-on-vaccine-safety COVID-19 rapid guideline: managing COVID-19: nice.org.uk/guidance/NG191 - The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

AstraZeneca jab: Under 30s to be offered alternative after 79 blood clot cases'Benefits outweigh risks': What the regulators said about the AstraZeneca vaccineModerna vaccine: First dose in UK given to 24-year-old as JCVI member says jab could be reserved for youngFrom transmission to efficacy: How all the Covid vaccines compare'Putin apologist': Alex Salmond refuses three times to say Russia behind Salisbury attackScotland poll: Nicola Sturgeon to win independence 'super-majority' without Alex Salmond's help'Ermmm... it's #SofaGate: 'Diplomatic fiasco' as Von der Leyen relegated to sofaFrom Bridgerton to Bond?: Why Regé-Jean Page is in the 007 frameMasters 2021: How Bryson DeChambeau is built to hit hard - and very, very longSave over 85pc on a Telegraph subscription to read all these articles. Enjoy four months for just £3. Sign up here: http://bit.ly/3b9VfyA

The JCVI have announced that under 30s should be offered an alternative to the Astra Zeneca vaccine. What does this mean for the vaccine rollout, and for young people who’ve already had the AZ jab? With Michael Walker, Deenan Pillay and Dalia Gebrial. What Are the AstraZeneca Blood Clot Risks?

You're listening to season 2 of the Penny's Hill Practice podcast! In this episode, Dr Geoff Hamp and Dr Sam McGinley are back to answer some more of the questions that you, our listeners, asked us about the Coronavirus Immunisations. We had such a good response and feedback to our first FAQ podcast episode but we've had lots more questions so we thought now was a good time to bring you the answers to your new questions in this week's episode. If you have a question about the Coronavirus immunisations and want us to answer it in Part 3, then email them to us at the address below or via the encrypted contact form on our website www.pennyshillpractice.co.uk/pennys-hill-practice-podcasts To see the JCVI cohorts in detail, have a look at the UK Government website here. For details about signing up to UK Coronavirus vaccine trials, have a look at the NHS website here. And if you haven't listened to our first FAQ podcast, click here and have a listen. You can use the national Covid Immunisation booking service here. To report any side effects from your Covid immunisation, use the MHRA site here. If you have any suggestions for topics you would like covered, email them to pennyshill.podcast@dorsetgp.nhs.uk and put the word "Podcast" as your subject, or leave us a message at https://anchor.fm/pennyshillpractice/message As always, please look after yourself and each other, stay safe, stay well and remember to keep smiling. Until next week! Runtime 20 minutes 31 seconds Released 22 March 2021 Music under license. Ref: 0214.053 --- Send in a voice message: https://anchor.fm/pennyshillpractice/message

In a slightly different talk evidence, Helen Macdonald and Duncan Jarvies are bringing you a couple, of in depth interviews, Firstly, Anthony Harnden, GP, academic and member of the UK's Joint Committee on Vaccination and Immunisation takes us inside their decision making, and explains what evidence they look at, how they assess it, and what the next year of vaccination may look like. Also in this episode, Gordon Guyatt, one of the founders of EBM, joins us to talk about Grade - the framework in which evidence for guidelines can be assessed - and explains why the most important thing is not the RCTs, but being very clear about what the guideline is supposed to achieve. https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation https://www.gradeworkinggroup.org/

In a slightly different talk evidence, Helen Macdonald and Duncan Jarvies are bringing you a couple, of in depth interviews, Firstly, Anthony Harnden, GP, academic and member of the UK's Joint Committee on Vaccination and Immunisation takes us inside their decision making, and explains what evidence they look at, how they assess it, and what the next year of vaccination may look like. Also in this episode, Gordon Guyatt, one of the founders of EBM, joins us to talk about Grade - the framework in which evidence for guidelines can be assessed - and explains why the most important thing is not the RCTs, but being very clear about what the guideline is supposed to achieve. https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation https://www.gradeworkinggroup.org/

Welcome back to season 2 of the Penny's Hill Practice podcast and this week there's a slight change in our schedule! In this episode, Dr Geoff Hamp and Dr Sam McGinley answer some of the questions that you, our listeners, asked us about the Coronavirus Immunisations. There's lots of questions and lots of answers out there but also quite a lot of incorrect information. So, as the Coronavirus vaccines are a bit of a hot topic at the moment, we asked you to ask us your questions and after just a week, we've had a full inbox. So, we've answered the questions we have received so far and brought the answers to you in this week's episode. If you have a question about the Coronavirus immunisations and want us to answer it in Part 2, then email them to us at the address below or via the encrypted contact form on our website www.pennyshillpractice.co.uk/pennys-hill-practice-podcasts To see the JCVI cohorts in detail, have a look at the UK Government website here. For details about signing up to UK Coronavirus vaccine trials, have a look at the NHS website here. And don't forget. if you are, or you know of a fellow UK healthcare professional who is struggling due to the stresses and pressures of the Covid-19 Pandemic, contact us using our contact details. We would love to hear from you to see what we can do to help. If you have any suggestions for topics you would like covered, email them to pennyshill.podcast@dorsetgp.nhs.uk and put the word "Podcast" as your subject, or leave us a message at https://anchor.fm/pennyshillpractice/message As always, please look after yourself and each other, stay safe, stay well and remember to keep smiling. Until next week! Runtime 31 minutes 21 seconds Released 25 January 2021 Music under license. --- Send in a voice message: https://anchor.fm/pennyshillpractice/message

An audio recording from the recent Community Vaccination Update hosted by the NHS, Southend Public Health team and SAVS. The speakers at this event were: Simon Williams, SEE Director of Primary Care & Partnerships and Integration Dr Bharat Pankhania, who is supporting the Southend Public Health team as a consultant during the pandemic Please note that information and guidance was accurate on the date of recording. For all the latest and information relating to Covid, sign up to the Community Connectors mailing list: https://www.surveymonkey.co.uk/r/RQ3Y7BR Updated information: Mixing doses PHE, the JCVI and the MHRA have all been very clear that in the absence of trial data to show it is safe and effective, doses should not be mixed. If you have a first dose of one vaccine, your second dose will be of that same vaccine too and that is what NHS organisations have been instructed to do.

Karen E. Nelson, Ph.D. is the President of the J. Craig Venter Institute (JCVI), which has received a grant from the Foundation for a Smoke-Free World. Prior to being appointed President, she held a number of other positions at the Institute, including Director of JCVI's Rockville Campus, and Director of Human Microbiology and Metagenomics in the Department of Human Genomic Medicine at JCVI. Dr. Nelson received her undergraduate degree from the University of the West Indies, and her Ph.D. from Cornell University. She has authored or co-authored over 200 peer reviewed publications, edited three books, and is currently Editor-in-Chief of the journal Microbial Ecology. Dr. Nelson is an elected member of the National Academy of Sciences. Other honors include being named ARCS Scientist of the Year 2017; a Fellow of the American Academy of Microbiology; being inducted into the Indian National Academy of Sciences in 2018; and being appointed an Honorary Professor at the University of the West Indies as well as a Helmholtz International Fellow. Dr. Nelson has extensive experience in microbial ecology, microbial genomics, microbial physiology and metagenomics. Dr. Nelson has led several genomic and metagenomic efforts, and led the first human metagenomics study that was published in 2006. Additional ongoing studies in her group include metagenomic approaches to study the ecology of the gastrointestinal tract of humans and animals, studies on the relationship between the microbiome and various human and animal disease conditions, reference genome sequencing and analysis primarily for the human body, and other -omics studies.